CILF: CRISPR/Cas9 based integration of large DNA fragments in Saccharomyces cerevisiae
Biotechnology and Bioengineering · 2024
DOI: 10.1002/bit.28830 ↗At a glance
Journal article in Biotechnology and Bioengineering, 2024. Written by Shijie Xu and 6 co-authors. Institution: Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Te…. Major MEDLINE topics: Saccharomyces cerevisiae, CRISPR-Cas Systems. Cited 5 times so far (Crossref); 19 references. Funded by: Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project, Key-Area Research and Development Program of Guangdong Province, National Natural Science Foundation of China.
Abstract (original language)
Genome integration technology has markedly expedited the construction of cell factories. However, its application is currently limited by the inefficient integration of large DNA fragments. Here, we report a CRISPR/Cas9 based integration of large DNA fragments (CILF) method to efficiently integrate large DNA fragments in Saccharomyces cerevisiae . In this approach, a fusion protein, Cas9‐Brex27‐FadR, was employed for the targeted delivery of donor plasmid to double‐strand breaks (DSBs), while simultaneously recruiting Rad51 to enhance the efficiency of homologous recombination (HR). Our findings demonstrate that this method can achieve an integration efficiency of 98% for 10 kb DNA fragments and nearly 80% for 40 kb DNA fragments at a single site, using donor plasmids with 1000 bp homology arms (HAs) and 12 FadR binding sites (BSs). The CILF technique significantly enriches the synthetic biology toolbox of S. cerevisiae , offering significant potential to propel advancements in both synthetic biology and metabolic engineering.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
- China National Research Institute of Food and Fermentation Industries, Beijing, China.
Funding
- Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project
- Key-Area Research and Development Program of Guangdong Province
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Cite
APA
Xu, S., Meng, J., Zhang, Q., Tong, B., Liu, Z., Fu, J., & Shi, S. (2024). CILF: CRISPR/Cas9 based integration of large DNA fragments in Saccharomyces cerevisiae. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28830
Vancouver
Xu S, Meng J, Zhang Q, Tong B, Liu Z, Fu J, et al. CILF: CRISPR/Cas9 based integration of large DNA fragments in Saccharomyces cerevisiae. Biotechnology and Bioengineering. 2024. doi:10.1002/bit.28830
BibTeX
@article{Xu2024,
author = {Xu, Shijie and Meng, Jie and Zhang, Qi and Tong, Baisong and Liu, Zihe and Fu, Jinyu and Shi, Shuobo},
title = {CILF: CRISPR/Cas9 based integration of large DNA fragments in Saccharomyces cerevisiae},
journal = {Biotechnology and Bioengineering},
year = {2024},
doi = {10.1002/bit.28830}
}
EUVIMED